RADIATION THERAPY ONCOLOGY GROUP
放射治疗肿瘤学组
基本信息
- 批准号:3557929
- 负责人:
- 金额:$ 4.19万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1984
- 资助国家:美国
- 起止时间:1984-04-01 至 1989-03-31
- 项目状态:已结题
- 来源:
- 关键词:bladder neoplasm carmustine cervix neoplasms cis platinum compound combination cancer therapy cooperative study esophagus neoplasm glioma head /neck neoplasm human subject human therapy evaluation lung neoplasms neoplasm /cancer chemotherapy neoplasm /cancer immunotherapy neoplasm /cancer radiation therapy neoplasm /cancer surgery oral pharyngeal neoplasm radiobiology radiosensitizer small cell lung cancer squamous cell carcinoma
项目摘要
The purpose of this project is to allow and support participation of Wayne
State University in the Radiation Therapy Oncology Group and to determine
which treatments are most efficacious in improving local control and
lowering morbidity in the treatment of adult patients with neoplasms using
the modalities of radiation therapy, chemotherapy and surgery. This should
be reflected in increased survival and decreased complications in patients
suffering from malignant diseases. The faculty cooperates with the
research aims of the Radiation Therapy Oncology Group to explore the
current best treatments for malignant disease.
Wayne State Univesity and the Michigan Cancer Foundation are a National
Cancer Institute recognized Comprehensive Cancer Center. In addition to
radiation therapy, various oncology specialists are well represented. Dr.
Al-Sarraf is the Chairman of the Medical Oncology Committee of the RTOG.
Dr. Jacobs is the Chariman of the Head and Neck Surgical Committee. The
Pathology Department has been well represented and has reviewed several
protocols.
The quality assurance efforts of our Physics/Statistics and Data Management
groups have led to an excellent past record in RTOG participation. The
Biological Sciences Section of the Radiation Therapy Department, under the
direction of Dr. Kenneth Honn, is presently exploring radiation protectors
which will be available for clinical trials in the near future. The
Radiation Oncology Center, in the past, has initiated numerous protocols,
especially in connection with cancer of the lung, esophagus, and head and
neck cancer. Its members serve on numerous Committees partially accounting
for the high rating of Wayne State University with the Radiation Therapy
Oncology Group. This institution is a major contributor of patient numbers
and participates in multi-modality group investigations. Wayne State
physicians are also active participants in the Southwest Oncology Group,
the Gastro-Intestinal Study Group and the Pediatric Oncology Group. The
faculty of the Radiation Oncology Center is expanding its patient base by
treating patients at Grace Hospital Division. We are submitting an
application for Sinai Hospital to join the grant. There is no doubt that
the Radiation Oncology Center is growing in patient numbers and that there
is a firm commitment of departmental physicians and scientists to group
studies.
这个项目的目的是允许和支持韦恩的参与
州立大学放射治疗肿瘤学小组,并确定
哪种治疗在改善局部控制方面最有效,
降低成人肿瘤患者的发病率
放射治疗、化疗和手术的方式。 这应该
反映在患者生存率的提高和并发症的减少
患有恶性疾病。 学院与
放射治疗肿瘤学组的研究目标是探索
目前治疗恶性疾病的最佳方法。
韦恩州立大学和密歇根癌症基金会是一个国家
癌症研究所认可的综合癌症中心。 除了
放射治疗,各种肿瘤学专家都有很好的代表。 博士
Al-Sarraf是RTOG医学肿瘤委员会主席。
博士雅各布斯是头颈外科委员会的主席。 的
病理学部门已得到充分代表,并已审查了几个
协议.
我们的物理/统计和数据管理的质量保证工作
在RTOG的参与方面有着出色的记录。 的
放射治疗部生物科学组,隶属于
Kenneth Honn博士的指导下,目前正在探索辐射保护器
其将在不久的将来用于临床试验。 的
放射肿瘤中心,在过去,已经启动了许多协议,
特别是与肺癌、食道癌和脑癌有关的癌症,
颈部癌症 其成员在许多委员会任职,部分原因是
韦恩州立大学放射治疗的高评价
肿瘤组。 该机构是患者数量的主要贡献者
并参与多模式小组调查。 韦恩州立大学
医生也是西南肿瘤学小组的积极参与者,
胃肠研究组和儿科肿瘤组。 的
放射肿瘤学中心的教师正在扩大其病人基础,
在格雷斯医院分部治疗病人 我们正在提交一份
西奈医院申请加入补助金。 毫无疑问
放射肿瘤学中心的病人数量正在增长,
是部门医生和科学家的坚定承诺,
问题研究
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
H GUNTER SEYDEL其他文献
H GUNTER SEYDEL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('H GUNTER SEYDEL', 18)}}的其他基金
相似海外基金
PHASE I STUDY OF O-6 BENZYLGUANINE AND CARMUSTINE IN ADVANCED CANCER
O-6 苄基鸟嘌呤和卡莫司汀治疗晚期癌症的 I 期研究
- 批准号:
6114488 - 财政年份:1998
- 资助金额:
$ 4.19万 - 项目类别:
STUDY OF THE SEQUENTIAL ADMINISTRATION OF CARMUSTINE AND TEMOZOLOMIDE
卡莫司汀和替莫唑胺序贯给药的研究
- 批准号:
6115223 - 财政年份:1998
- 资助金额:
$ 4.19万 - 项目类别:
STUDY OF THE SEQUENTIAL ADMINISTRATION OF CARMUSTINE AND TEMOZOLOMIDE
卡莫司汀和替莫唑胺序贯给药的研究
- 批准号:
6276457 - 财政年份:1997
- 资助金额:
$ 4.19万 - 项目类别:
PHASE I TRIAL AND PHARMACOKINETIC STUDY OF CARMUSTINE AND TEMOZOLOMIDE
卡莫司汀和替莫唑胺的 I 期试验和药代动力学研究
- 批准号:
6245680 - 财政年份:1997
- 资助金额:
$ 4.19万 - 项目类别:
PHASE I STUDY OF O-6 BENZYLGUANINE AND CARMUSTINE IN ADVANCED CANCER
O-6 苄基鸟嘌呤和卡莫司汀治疗晚期癌症的 I 期研究
- 批准号:
6245581 - 财政年份:1997
- 资助金额:
$ 4.19万 - 项目类别:
PHASE I STUDY OF O-6 BENZYLGUANINE AND CARMUSTINE IN ADVANCED CANCER
O-6 苄基鸟嘌呤和卡莫司汀治疗晚期癌症的 I 期研究
- 批准号:
6275723 - 财政年份:1997
- 资助金额:
$ 4.19万 - 项目类别:
IMAGING OF CARMUSTINE & TAXOL UPTAKE IN HUMAN BRAIN CANCER (H80) CELLS
卡莫司汀的成像
- 批准号:
6252990 - 财政年份:1997
- 资助金额:
$ 4.19万 - 项目类别:
PHASE I TRIAL AND PHARMACOKINETIC STUDY OF CARMUSTINE AND TEMOZOLOMIDE
卡莫司汀和替莫唑胺的 I 期试验和药代动力学研究
- 批准号:
6275794 - 财政年份:1997
- 资助金额:
$ 4.19万 - 项目类别:
STUDY OF THE SEQUENTIAL ADMINISTRATION OF CARMUSTINE (BCNU) AND TEMOZOLOMIDE
卡莫司汀 (BCNU) 和替莫唑胺序贯给药的研究
- 批准号:
6246391 - 财政年份:1997
- 资助金额:
$ 4.19万 - 项目类别:
ECOG 91140--CDP, DTIC, CARMUSTINE & TAMOXIFEN VS DTIC IN ADVANCED MELANOMA
ECOG 91140--CDP、DTIC、卡莫司汀
- 批准号:
6246895 - 财政年份:1997
- 资助金额:
$ 4.19万 - 项目类别: